Publication: Development of phenotypic and transcriptional biomarkers to evaluate relative activity of potentially estrogenic chemicals in ovariectomized mice
Issued Date
2015-01-01
Resource Type
ISSN
15529924
00916765
00916765
Other identifier(s)
2-s2.0-84961289196
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Environmental Health Perspectives. Vol.123, No.4 (2015), 344-352
Suggested Citation
Sylvia C. Hewitt, Wipawee Winuthayanon, Brianna Pockette, Robnet T. Kerns, Julie F. Foley, Norris Flagler, Elizabeth Ney, Apichart Suksamrarn, Pawinee Piyachaturawat, Pierre R. Bushel, Kenneth S. Korach Development of phenotypic and transcriptional biomarkers to evaluate relative activity of potentially estrogenic chemicals in ovariectomized mice. Environmental Health Perspectives. Vol.123, No.4 (2015), 344-352. doi:10.1289/ehp.1307935 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/36020
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Development of phenotypic and transcriptional biomarkers to evaluate relative activity of potentially estrogenic chemicals in ovariectomized mice
Abstract
© 2015, Public Health Services, US Dept of Health and Human Services. All rights reserved Background: Concerns regarding potential endocrine-disrupting chemicals (EDCs) have led to a need for methods to evaluate candidate estrogenic chemicals. Our previous evaluations of two such EDCs revealed a response similar to that of estradiol (E2) at 2 hr, but a less robust response at 24 hr, similar to the short-acting estrogen estriol (E3). Objectives: Microarray analysis using tools to recognize patterns of response have been utilized in the cancer field to develop biomarker panels of transcripts for diagnosis and selection of treatments most likely to be effective. Biological effects elicited by long- versus short-acting estrogens greatly affect the risks associated with exposures; therefore, we sought to develop tools to predict the ability of chemicals to maintain estrogenic responses. Methods: We used biological end points in uterine tissue and a signature pattern–recognizing tool that identified coexpressed transcripts to develop and test a panel of transcripts in order to classify potentially estrogenic compounds using an in vivo system. The end points used are relevant to uterine tissue, but the resulting classification of the compounds is important for other sensitive tissues and species. results: We evaluated biological and transcriptional end points with proven short- and long-acting estrogens and verified the use of our approach using a phytoestrogen. With our model, we were able to classify the diarylheptanoid D3 as a short-acting estrogen. conclusions: We have developed a panel of transcripts as biomarkers which, together with biological end points, might be used to screen and evaluate potentially estrogenic chemicals and infer mode of activity.